Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

View source ↗

Summary

This clinical trial update describes the ongoing FINE-REAL study evaluating finerenone in routine medical care for people with chronic kidney disease and type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kerendia (finerenone)

Snippet

Sponsor: Bayer | Conditions: Chronic Kidney Disease, Type 2 Diabetes Mellitus | Status: ACTIVE_NOT_RECRUITING